PAI
ProQuest Associates IV Portfolio holdings
AUM
$53M
This Quarter Return
+118.08%
1 Year Return
+3.35%
3 Year Return
+116.54%
5 Year Return
–
10 Year Return
–
AUM
$307M
AUM Growth
+$307M
(+55%)
Cap. Flow
-$5.31M
Cap. Flow
% of AUM
-1.73%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
3
Reduced
1
Closed
1
Top Buys
| 1 |
AGRX
Agile Therapeutics, Inc
AGRX
|
$7.53M |
| 2 |
ANTH
Anthera Pharmaceuticals, Inc.
ANTH
|
$2.91M |
| 3 |
ZSAN
Zosano Pharma Corporation
ZSAN
|
$2.32M |
| 4 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
$1.63M |
Top Sells
| 1 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$13.8M |
| 2 |
IMDZ
Immune Design Corp.
IMDZ
|
$5.95M |
Sector Composition
| 1 | Healthcare | 69.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGRX
1
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $200M | 65.32% | 4,780,188 +39,001 | +0.8% | +$1.63M |
|
|
IMDZ
2
DELISTED
Immune Design Corp.
IMDZ
| $51M | 16.62% | 2,414,040 -281,717 | -10% | -$5.95M |
|
|
AGRX
3
DELISTED
Agile Therapeutics, Inc
AGRX
| $43.3M | 14.12% | 4,668,763 +812,066 | +21% | +$7.53M |
|
|
ANTH
4
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $8.49M | 2.77% | 1,900,000 +650,000 | +52% | +$2.91M |
|
|
ZSAN
5
DELISTED
Zosano Pharma Corporation
ZSAN
| $2.32M | 0.76% | +229,759 | New | +$2.32M |
|
6
Savara
SVRA
$567M
| $1.24M | 0.4% | 2,551,851 | – | – |
|
|
ACHN
7
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| – | – | -1,122,957 | Closed | -$13.8M |
|